The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
The CIRCULATE Spain study: Circulating tumor DNA based decision for adjuvant treatment in localized colon cancer.
 
Noelia Tarazona
Consulting or Advisory Role - Guardant Health; Merck
Speakers' Bureau - Amgen; Merck; Pfizer; SERVIER
Travel, Accommodations, Expenses - Amgen; Merck; Roche
 
Juan Antonio Carbonell-Asins
No Relationships to Disclose
 
Maria Jose Safont
Consulting or Advisory Role - Amgen; Merck; Pierre Fabre; SERVIER
Speakers' Bureau - Amgen
Travel, Accommodations, Expenses - Amgen; Merck; Pierre Fabre; SERVIER
 
Elena Elez
Honoraria - Amgen; Array BioPharma; Bristol-Myers Squibb; Merck; Merck Serono; Novartis; Roche; Sanofi/Aventis; Seagan; SERVIER
Consulting or Advisory Role - Amgen; Array BioPharma; Bayer; Bristol Myers Squibb; Merck Serono; MSD; Pierre Fabre; Roche; Sanofi; SERVIER
Research Funding - Amgen (Inst); Array BioPharma (Inst); AstraZeneca (Inst); BeiGene (Inst); Boehringer Ingelheim (Inst); Bristol-Myers Squibb (Inst); Celgene (Inst); Debiopharm Group (Inst); Genentech (Inst); HalioDx (Inst); Hutchison MediPharma (Inst); Janssen-Cilag SA (Inst); MedImmune (Inst); Menarini (Inst); Merck (Inst); Merck Sharp&Dohme de España SA (Inst); Merus NV (Inst); Mirati Therapeutics (Inst); Novartis (Inst); Pfizer (Inst); PharmaMar (Inst); Pierre Fabre (Inst); Roche (Inst); Sanofi (Inst); SERVIER (Inst); Taiho Pharmaceutical (Inst)
Travel, Accommodations, Expenses - Amgen; Array BioPharma; Bristol-Myers Squibb; Merck Serono; Roche; Sanofi; SERVIER
 
Josep Tabernero
Stock and Other Ownership Interests - Oniria Therapeutics
Consulting or Advisory Role - Array BioPharma; AstraZeneca; Bayer; Boehringer Ingelheim; Cardiff Oncology; Chugai Pharma; Daiichi Sankyo; F. Hoffmann LaRoche; Genentech; HalioDx; Hutchison MediPharma; Ikena Oncology; Inspirna; IQvia; Lilly; Menarini; Merck Serono; Merus; Mirati Therapeutics; MSD; Neophore; Novartis; Ona Therapeutics; Orion Biotechnology; Peptomyc; Pfizer; Pierre Fabre; Samsung Bioepis; Sanofi; Scandion Oncology; Scorpion Therapeutics; Seagen; Servier; Sotio; Taiho Pharmaceutical; Tessa Therapeutics; TheraMyc; Tolremo
Other Relationship - Imedex/HMP; Medscape; MJH Life Sciences; Peerview; Physicans' Education Resource
 
Cristina Santos
Consulting or Advisory Role - Amgen
Speakers' Bureau - Amgen
Travel, Accommodations, Expenses - Amgen; Merck
 
Joana Vidal Barrull
Consulting or Advisory Role - Amgen; Bristol-Myers Squibb; Merck
Speakers' Bureau - Amgen; Bristol-Myers Squibb; Merck; Sanofi
Travel, Accommodations, Expenses - Merck
 
Luis Robles Díaz
No Relationships to Disclose
 
Cristina Gravalos
Honoraria - Amgen; Incyte; Merck; SERVIER
Consulting or Advisory Role - Amgen; SERVIER
Research Funding - Daiichi Sankyo Pharmaceutical; Pfizer; SERVIER
 
Mireia Gil Raga
Speakers' Bureau - Amgen; Lilly O.; Merck; SERVIER
Travel, Accommodations, Expenses - Amgen; Lilly O.; Merck
 
Mercedes Martínez Villacampa
No Relationships to Disclose
 
Maria Auxilidora Gomez-España
Travel, Accommodations, Expenses - Amgen; Merck; Roche
 
Jorge Martín-Arana
No Relationships to Disclose
 
Laura Olivares Ordóñez
No Relationships to Disclose
 
Pilar Rentero-Garrido
No Relationships to Disclose
 
Enrique Aranda
Consulting or Advisory Role - Amgen; Bayer; Bristol-Myers Squibb; Merck; Roche; Sanofi; SERVIER
Research Funding - Roche
 
Clara O Montagut
Consulting or Advisory Role - Biocartis; Guardant Health; Merck Serono; Sanofi/Aventis
Speakers' Bureau - Amgen; Guardant Health; Merck Serono; Roche/Genentech
Research Funding - Symphogen
Patents, Royalties, Other Intellectual Property - Patent licensed by Biocartis (Inst)
 
Andres Cervantes
Consulting or Advisory Role - Amgen (Inst); Foundation Medicine (Inst); Merck Serono (Inst); Roche (Inst); Transgene (Inst)
Research Funding - Actuate Therapeutics (Inst); Adaptimmune (Inst); Amcure (Inst); Amgen (Inst); Astellas Pharma (Inst); AstraZeneca Spain (Inst); Bayer (Inst); BeiGene (Inst); BMSi (Inst); FibroGen (Inst); Genentech (Inst); Lilly (Inst); MedImmune (Inst); Merck Serono (Inst); MSD (Inst); Natera (Inst); Novartis (Inst); SERVIER (Inst); Sierra Oncology (Inst); Takeda (Inst)
Other Relationship - Annals of Oncology; Cancer Treatment Reviews; ESMO Open